Cargando…
Rcn3 Suppression Was Responsible for Partial Relief of Emphysema as Shown by Specific Type II Alveolar Epithelial Cell Rcn3 CKO Mouse Model
BACKGROUND: Chronic obstructive pulmonary disease (COPD), characterized by irreversible airflow limitation, is a highly prevalent lung disease worldwide and imposes increasing disease burdens globally. Emphysema is one of the primary pathological features contributing to the irreversible decline of...
Autores principales: | Zhang, Qianyu, Wang, Tong, Jin, Jiawei, Shi, Xiaoqian, Huang, Aiben, Ma, Zhenru, Li, Jiujie, Wang, Shiyu, Z. Ma, Runlin, Fang, Qiuhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847372/ https://www.ncbi.nlm.nih.gov/pubmed/33531801 http://dx.doi.org/10.2147/COPD.S272711 |
Ejemplares similares
-
TGFβ1-RCN3-TGFBR1 loop facilitates pulmonary fibrosis by orchestrating fibroblast activation
por: Wu, Mingting, et al.
Publicado: (2023) -
Rare coding variants in RCN3 are associated with blood pressure
por: He, Karen Y., et al.
Publicado: (2022) -
Integrative Analyses and Verification of the Expression and Prognostic Significance for RCN1 in Glioblastoma Multiforme
por: Lu, Weicheng, et al.
Publicado: (2021) -
Partial Inhibition of Calcineurin Activity by Rcn2 as a Potential Remedy for Vps13 Deficiency
por: Wardaszka, Patrycja, et al.
Publicado: (2021) -
Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy
por: Ding, Jian, et al.
Publicado: (2022)